Actual performance and results may differ materially from those results anticipated by our guidance and other forward-looking statements made in this release depending on a variety of factors, including, but not limited to: developments in the U.S. government defense and non-defense budgets, including budget reductions, sequestration, implementation of spending limits or changes in budgetary priorities, delays in the U.S. government budget process or a government shutdown, or the U.S. government's failure to raise the debt ceiling, which increases the possibility of a default by the U.S. government on its debt obligations, related credit-rating downgrades, or an economic recession; uncertainties in tax due to new tax legislation or other regulatory developments; inflationary pressures and fluctuations in interest rates; delays in the U.S. government contract procurement process or the award of contracts and delays or loss of contracts as a result of competitor protests; changes in U.S. government procurement rules, regulations and practices; our compliance with various U.S. government and other government procurement rules and regulations; governmental reviews, audits and investigations of our company; our ability to effectively compete and win contracts with the U.S. government and other customers; our ability to respond rapidly to emerging technology trends, including the use of artificial intelligence; our reliance on information technology spending by hospitals/healthcare organizations; our reliance on infrastructure investments by industrial and natural resources organizations; energy efficiency and alternative energy sourcing investments; investments by U.S. government and commercial organizations in environmental impact and remediation projects; the effects of health epidemics, pandemics and similar outbreaks may have on our business, financial position, results of operations and/or cash flows; our ability to attract, train and retain skilled employees, including our management team, and to obtain security clearances for our employees; our ability to accurately estimate costs, including cost increases due to inflation, associated with our firm-fixed-price contracts and other contracts; resolution of legal and other disputes with our customers and others or legal or regulatory compliance issues; cybersecurity, data security or other security threats, system failures or other disruptions of our business; our compliance with international, federal, state and local laws and regulations regarding privacy, data security, protection, storage, retention, transfer and disposal, technology protection and personal information; the damage and disruption to our business resulting from natural disasters and the effects of climate change; our ability to effectively acquire businesses and make investments; our ability to maintain relationships with prime contractors, subcontractors and joint venture partners; our ability to manage performance and other risks related to customer contracts; the failure of our inspection or detection systems to detect threats; the adequacy of our insurance programs, customer indemnifications or other liability protections designed to protect us from significant product or other liability claims, including cybersecurity attacks; our ability to manage risks associated with our international business; our ability to comply with the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act of 2010 and similar worldwide anti-corruption and anti-bribery laws and regulations; our ability to protect our intellectual property and other proprietary rights by third parties of infringement, misappropriation or other violations by us of their intellectual property rights; our ability to prevail in litigation brought by third parties of infringement, misappropriation or other violations by us of their intellectual property rights; our ability to declare or increase future dividends based on our earnings, financial condition, capital requirements and other factors, including compliance with applicable law and our agreements; our ability to grow our commercial health and infrastructure businesses, which could be negatively affected by budgetary constraints faced by hospitals and by developers of energy and infrastructure projects; our ability to successfully integrate acquired businesses; and our ability to execute our business plan and long-term management initiatives effectively and to overcome these and other known and unknown risks that we face.
These are only some of the factors that may affect the forward-looking statements contained in this release. For further information concerning risks and uncertainties associated with our business, please refer to the filings we make from time to time with the U.S. Securities and Exchange Commission ("SEC"), including the "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Legal Proceedings" sections of our latest Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, all of which may be viewed or obtained through the Investor Relations section of our website at www.leidos.com.
All information in this release is as of October 29, 2024. Leidos expressly disclaims any duty to update the guidance or any other forward-looking statement provided in this release to reflect subsequent events, actual results or changes in Leidos' expectations. Leidos also disclaims any duty to comment upon or correct information that may be contained in reports published by investment analysts or others.
CONTACTS: |
|
|
|
|
|
Investor Relations: |
| Media Relations: |
Stuart Davis |
| Alyssa Pettus |
571.526.6124 |
| 571.526.6743 |
|
LEIDOS HOLDINGS, INC. UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in millions, except per share data) | ||||||||
| ||||||||
|
| Three Months Ended |
| Nine Months Ended | ||||
|
| September 27,
|
| September 29,
|
| September 27,
|
| September 29,
|
Revenues |
| $ 4,190 |
| $ 3,921 |
| $ 12,297 |
| $ 11,458 |
Cost of revenues |
| 3,428 |
| 3,334 |
| 10,192 |
| 9,809 |
Selling, general and administrative expenses |
| 247 |
| 239 |
| 704 |
| 709 |
Acquisition, integration and restructuring costs |
| 3 |
| 5 |
| 14 |
| 14 |
Goodwill impairment charges |
| — |
| 599 |
| — |
| 599 |
Asset impairment charges |
| 6 |
| 88 |
| 6 |
| 88 |
Equity earnings of non-consolidated subsidiaries |
| (10) |
| (8) |
| (25) |
| (21) |
Operating income (loss) |
| 516 |
| (336) |
| 1,406 |
| 260 |
Non-operating income (expense): |
|
|
|
|
|
|
|
|
Interest expense, net |
| (46) |
| (53) |
| (146) |
| (163) |
Other income (expense), net |
| — |
| 1 |
| 4 |
| (4) |
Income (loss) before income taxes |
| 470 |
| (388) |
| 1,264 |
| 93 |
Income tax expense |
| (108) |
| (8) |
| (295) |
| (115) |
Net income (loss) |
| 362 |
| (396) |
| 969 |
| (22) |
Less: net (loss) income attributable to non-controlling interest |
| (2) |
| 3 |
| (1) |
| 8 |
Net income (loss) attributable to Leidos common stockholders |
| $ 364 |
| $ (399) |
| $ 970 |
| $ (30) |
|
|
|
|
|
|
|
|
|
Earnings per share: |
|
|
|
|
|
|
|
|
Basic |
| $ 2.72 |
| $ (2.91) |
| $ 7.19 |
| $ (0.22) |
Diluted |
| 2.68 |
| (2.91) |
| 7.13 |
| (0.22) |
|
|
|
|
|
|
|
|
|
Weighted average number of common shares outstanding: |
|
|
|
|
|
|
|
|
Basic |
| 134 |
| 137 |
| 135 |
| 137 |
Diluted |
| 136 |
| 137 |
| 136 |
| 137 |
|
|
|
|
|
|
|
|
|
Cash dividends declared per share |
| $ 0.38 |
| $ 0.36 |
| $ 1.14 |
| $ 1.08 |